Astrana Health, Inc. (ASTH)

Quarterly Report Filed: 2026-05-08

Key Insights

Q1 2026 filing shows Astrana Health operating multiple business segments (Care Delivery, Care Enablement, Care Partners) with complex intercompany relationships and equity method investments, indicating a diversified healthcare platform strategy.
The company maintains multiple credit facilities and financing arrangements (revolving credit, term loans, SOFR-based pricing) as of March 31, 2026, suggesting active debt management and refinancing activities during the period.
Significant customer concentration risk is evident with named payors (Payor A, B, D) and related party transactions with AHMC, indicating dependency on key relationships that warrant monitoring for contract renewals and rate negotiations.
Recent acquisition of Prospect Medical Holdings' certain businesses and assets (as of July 1, 2025) suggests active M&A strategy to expand care delivery capabilities and network relationships.
The company carries contingent consideration liabilities and fair value measurements across multiple levels, indicating earnout obligations from acquisitions that could impact future cash flows and earnings.

Insider Trading Filed: 2026-04-15

Key Insights

Chandan Basho, the COO and CFO of Astrana Health, Inc., has disposed of 3,870 shares of common stock through a withholding transaction to cover tax obligations on vested restricted stock.
Basho continues to hold a significant number of shares, including 167,765 shares of common stock and unvested restricted stock units that will vest over the next year.
The transaction appears to be a routine tax withholding event and does not necessarily indicate a negative view of the company's prospects.

Insider Trading Filed: 2026-04-08

Key Insights

Insider Brandon Sim, the CEO and President, acquired a substantial amount of 201,056 restricted stock units in Astrana Health, Inc. (ASTH), indicating his confidence in the company's future.
Sim also holds significant indirect ownership in the company through the Sim Family Irrevocable Trust 2021 and the Brandon Sim 2020 Irrevocable Trust, suggesting long-term alignment with shareholders.
The vesting schedule for the restricted stock units, with eight semi-annual installments starting in October 2026, suggests a long-term commitment by the CEO to the company's success.

Insider Trading Filed: 2026-04-08

Key Insights

The reporting person, Kenneth T. Sim, is the Executive Chairman of Astrana Health, Inc. and owns a significant amount of the company's stock, both directly and indirectly through various trusts and entities.
Sim has recently been granted 100,000 restricted stock units (RSUs) that will vest in eight semi-annual installments, indicating the company is incentivizing him with equity-based compensation.
Sim also has additional unvested restricted stock grants that will vest over the next two years, further aligning his interests with those of the company and shareholders.

Insider Trading Filed: 2026-04-08

Key Insights

Insider Thomas Lam acquired 41,667 restricted stock units, vesting over 4 years, demonstrating his long-term commitment to Astrana Health.
Lam also holds a substantial indirect ownership stake of over 7.2 million shares through his roles at Allied Physicians and a family trust, aligning his interests with other shareholders.
The restricted stock grants and insider ownership suggest a positive outlook from management on Astrana Health's future growth and performance.

Insider Trading Filed: 2026-03-30

Key Insights

The reporting person, Glenn Sobotka, is the Chief Accounting Officer of Astrana Health, Inc. and is reporting the disposition of 662 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock.
Sobotka continues to beneficially own 14,039 shares of Astrana Health's common stock, including 4,824 shares of restricted stock that will vest over the next three years and 8,269 shares of performance-based restricted stock.
The transaction appears to be a routine tax withholding event and does not indicate any significant change in Sobotka's ownership position or his confidence in the company.

Current Report Filed: 2026-03-30

Key Insights

Astrana Health completed the acquisition of Prospect Health Plan, Inc. and Alta Newport Hospital, LLC, significantly expanding its healthcare services and provider network.
The company has provided unaudited interim financial statements and a pro forma statement of operations to give investors more visibility into the financial impact of the acquisition.
The transaction appears to be a strategic move to grow Astrana Health's market presence and service offerings, though the financial results will need to be closely monitored going forward.

Annual Report Filed: 2026-03-12

Key Insights

The company has significant investments in related party entities, including Collaborative Health Systems LLC, Apollo Sun Labs Management LLC, and Advanced Diagnostic and Surgical Center Inc., which could pose potential conflicts of interest and risks.
Astrana Health has a revolving credit facility and term loans that expose the company to interest rate risk, with the maximum interest rate on the loans reaching over 25% as of the most recent filing.
The company's revenue is heavily concentrated in a few major payors, with Payor A and Payor C accounting for a significant portion of accounts receivable, indicating potential customer concentration risk.

Insider Trading Filed: 2026-03-09

Key Insights

Insider Chandan Basho, the COO and CFO of Astrana Health, Inc. (ASTH), sold 1,240 shares of common stock on March 5, 2026, likely to cover tax withholding obligations on vesting of restricted stock units.
Basho still holds a significant number of unvested restricted stock and restricted stock units, totaling 57,149 shares, which will continue to vest over the next two years, aligning his interests with those of shareholders.
The insider transaction appears to be routine in nature and likely not indicative of a broader negative sentiment on the company or its prospects.

Insider Trading Filed: 2026-03-09

Key Insights

Insider Dinesh M. Kumar, the Chief Medical Officer, disposed of 1,697 shares of Astrana Health, Inc. (ASTH) common stock on March 5, 2026, likely to cover tax withholding obligations associated with vesting restricted stock units.
Kumar continues to hold a significant ownership stake in Astrana Health, with 200,335 shares beneficially owned, including unvested restricted stock and restricted stock units.
The filing indicates that Kumar's equity compensation is tied to both time-based vesting and achievement of certain performance goals, which could signal the company's focus on aligning executive incentives with long-term shareholder value creation.

Insider Trading Filed: 2026-03-09

Key Insights

Insider Thomas S. Lam, a director of Astrana Health, Inc., sold 9,266 shares of common stock on March 5, 2026, likely to cover tax withholding obligations associated with vesting of restricted stock.
Lam still holds a significant beneficial ownership stake in the company, with 423,990 direct shares and additional 7,266,508 shares held indirectly through two entities.
The transaction appears to be a routine stock sale by an insider to cover tax obligations, rather than a significant change in Lam's overall ownership position.

Current Report Filed: 2026-03-02

Key Insights

Astrana Health expects to report a material weakness in its internal control over financial reporting, particularly related to acquisition and purchase accounting processes. This could raise concerns about the company's financial reporting quality.
The company plans to file its 2025 Form 10-K within the 15-day extension period, indicating potential delays in reporting annual results.
Astrana Health has increased the size of its share repurchase program from $50 million to $100 million, signaling management's confidence in the intrinsic value of the company's stock.

Insider Trading Filed: 2026-01-27

Key Insights

Dinesh M. Kumar, the Chief Medical Officer of Astrana Health, Inc., recently disposed of 10,759 shares of the company's common stock to cover tax withholding obligations associated with vesting restricted stock.
Kumar currently holds 202,032 shares of Astrana Health, including 28,378 shares of restricted stock that will vest in 2027, as well as grants of 8,158 and 3,264 shares subject to performance goals, and 67,238 and 23,364 restricted stock units.
The insider transaction appears to be a routine cash-for-share exchange for tax purposes and does not necessarily indicate any significant change in Kumar's long-term outlook on the company.

Insider Trading Filed: 2026-01-15

Key Insights

The reporting person, David Schmidt, has exercised 20,000 stock options at a price of $5.79 and disposed of 4,269 shares at $27.12, indicating a mix of insider buying and selling activity.
Schmidt continues to beneficially own 31,494 shares of Astrana Health, Inc. (ASTH), including 6,449 shares of restricted stock that will vest in the near future.
The timing of the transactions, occurring on January 13, 2026, suggests the reporting person may have knowledge of upcoming company events or performance.

Current Report Filed: 2026-01-12

Key Insights

Astrana Health, Inc. updated its corporate presentation, indicating potential new developments or initiatives the company plans to present at upcoming conferences and meetings.
The company's filing notes that the information in the presentation is being furnished and not 'filed', suggesting the content may be more aspirational or forward-looking in nature.
The company cautions that it does not undertake to update the information in the presentation, which could signal the content is subject to change or uncertainty.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information